Cargando…

Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity

BACKGROUND: Equine herpesvirus type 1 (EHV-1) induces respiratory infection, abortion, and neurologic disease with significant impact. Virulence factors contributing to infection and immune evasion are of particular interest. A potential virulence factor of the neuropathogenic EHV-1 strain Ab4 is OR...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnabel, Christiane L., Wimer, Christine L., Perkins, Gillian, Babasyan, Susanna, Freer, Heather, Watts, Christina, Rollins, Alicia, Osterrieder, Nikolaus, Wagner, Bettina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106926/
https://www.ncbi.nlm.nih.gov/pubmed/30134896
http://dx.doi.org/10.1186/s12917-018-1563-4
_version_ 1783349873431543808
author Schnabel, Christiane L.
Wimer, Christine L.
Perkins, Gillian
Babasyan, Susanna
Freer, Heather
Watts, Christina
Rollins, Alicia
Osterrieder, Nikolaus
Wagner, Bettina
author_facet Schnabel, Christiane L.
Wimer, Christine L.
Perkins, Gillian
Babasyan, Susanna
Freer, Heather
Watts, Christina
Rollins, Alicia
Osterrieder, Nikolaus
Wagner, Bettina
author_sort Schnabel, Christiane L.
collection PubMed
description BACKGROUND: Equine herpesvirus type 1 (EHV-1) induces respiratory infection, abortion, and neurologic disease with significant impact. Virulence factors contributing to infection and immune evasion are of particular interest. A potential virulence factor of the neuropathogenic EHV-1 strain Ab4 is ORF2. This study on 24 Icelandic horses, 2 to 4 years of age, describes the infection with EHV-1 Ab4, or its deletion mutant devoid of ORF2 (Ab4ΔORF2) compared to non-infected controls (each group n = 8). The horses’ clinical presentation, virus shedding, viremia, antibody and cellular immune responses were monitored over 260 days after experimental infection. RESULTS: Infection with Ab4ΔORF2 reduced fever and minimized nasal virus shedding after infection compared to the parent virus strain Ab4, while Ab4ΔORF2 established viremia similar to Ab4. Concurrently with virus shedding, intranasal cytokine and interferon α (IFN-α) production increased in the Ab4 group, while horses infected with Ab4ΔORF2 expressed less IFN-α. The antibody response to EHV-1 was evaluated by a bead-based multiplex assay and was similar in both infected groups, Ab4 and Ab4ΔORF2. EHV-1 specific immunoglobulin (Ig) G1 was induced 8 days after infection (d8 pi) with a peak on d10–12 pi. EHV-1 specific IgG4/7 increased starting on d10 pi, and remained elevated in serum until the end of the study. The intranasal antibody response to EHV-1 was dominated by the same IgG isotypes and remained elevated in both infected groups until d130 pi. In contrast to the distinct antibody response, no induction of EHV-1 specific T-cells was detectable by flow cytometry after ex vivo re-stimulation of peripheral blood mononuclear cells (PBMC) with EHV-1 in any group. The cellular immune response was characterized by increased secretion of IFN-γ and interleukin10 in response to ex vivo re-stimulation of PBMC with EHV-1. This response was present during the time of viremia (d5–10 pi) and was similar in both infected groups, Ab4 and Ab4ΔORF2. CONCLUSIONS: ORF2 is a virulence factor of EHV-1 Ab4 with impact on pyrexia and virus shedding from the nasal mucosa. In contrast, ORF2 does not influence viremia. The immunogenicity of the Ab4ΔORF2 and parent Ab4 viruses are identical. GRAPHICAL ABSTRACT: Graphical abstract – Deletion of ORF2 reduces virulence of EHV-1 Ab4. Graphical summary of the main findings of this study: ORF2 is a virulence factor of EHV-1 Ab4 with impact on pyrexia and virus shedding from the nasal mucosa. [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12917-018-1563-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6106926
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61069262018-08-29 Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity Schnabel, Christiane L. Wimer, Christine L. Perkins, Gillian Babasyan, Susanna Freer, Heather Watts, Christina Rollins, Alicia Osterrieder, Nikolaus Wagner, Bettina BMC Vet Res Research Article BACKGROUND: Equine herpesvirus type 1 (EHV-1) induces respiratory infection, abortion, and neurologic disease with significant impact. Virulence factors contributing to infection and immune evasion are of particular interest. A potential virulence factor of the neuropathogenic EHV-1 strain Ab4 is ORF2. This study on 24 Icelandic horses, 2 to 4 years of age, describes the infection with EHV-1 Ab4, or its deletion mutant devoid of ORF2 (Ab4ΔORF2) compared to non-infected controls (each group n = 8). The horses’ clinical presentation, virus shedding, viremia, antibody and cellular immune responses were monitored over 260 days after experimental infection. RESULTS: Infection with Ab4ΔORF2 reduced fever and minimized nasal virus shedding after infection compared to the parent virus strain Ab4, while Ab4ΔORF2 established viremia similar to Ab4. Concurrently with virus shedding, intranasal cytokine and interferon α (IFN-α) production increased in the Ab4 group, while horses infected with Ab4ΔORF2 expressed less IFN-α. The antibody response to EHV-1 was evaluated by a bead-based multiplex assay and was similar in both infected groups, Ab4 and Ab4ΔORF2. EHV-1 specific immunoglobulin (Ig) G1 was induced 8 days after infection (d8 pi) with a peak on d10–12 pi. EHV-1 specific IgG4/7 increased starting on d10 pi, and remained elevated in serum until the end of the study. The intranasal antibody response to EHV-1 was dominated by the same IgG isotypes and remained elevated in both infected groups until d130 pi. In contrast to the distinct antibody response, no induction of EHV-1 specific T-cells was detectable by flow cytometry after ex vivo re-stimulation of peripheral blood mononuclear cells (PBMC) with EHV-1 in any group. The cellular immune response was characterized by increased secretion of IFN-γ and interleukin10 in response to ex vivo re-stimulation of PBMC with EHV-1. This response was present during the time of viremia (d5–10 pi) and was similar in both infected groups, Ab4 and Ab4ΔORF2. CONCLUSIONS: ORF2 is a virulence factor of EHV-1 Ab4 with impact on pyrexia and virus shedding from the nasal mucosa. In contrast, ORF2 does not influence viremia. The immunogenicity of the Ab4ΔORF2 and parent Ab4 viruses are identical. GRAPHICAL ABSTRACT: Graphical abstract – Deletion of ORF2 reduces virulence of EHV-1 Ab4. Graphical summary of the main findings of this study: ORF2 is a virulence factor of EHV-1 Ab4 with impact on pyrexia and virus shedding from the nasal mucosa. [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12917-018-1563-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-22 /pmc/articles/PMC6106926/ /pubmed/30134896 http://dx.doi.org/10.1186/s12917-018-1563-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Schnabel, Christiane L.
Wimer, Christine L.
Perkins, Gillian
Babasyan, Susanna
Freer, Heather
Watts, Christina
Rollins, Alicia
Osterrieder, Nikolaus
Wagner, Bettina
Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity
title Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity
title_full Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity
title_fullStr Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity
title_full_unstemmed Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity
title_short Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity
title_sort deletion of the orf2 gene of the neuropathogenic equine herpesvirus type 1 strain ab4 reduces virulence while maintaining strong immunogenicity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106926/
https://www.ncbi.nlm.nih.gov/pubmed/30134896
http://dx.doi.org/10.1186/s12917-018-1563-4
work_keys_str_mv AT schnabelchristianel deletionoftheorf2geneoftheneuropathogenicequineherpesvirustype1strainab4reducesvirulencewhilemaintainingstrongimmunogenicity
AT wimerchristinel deletionoftheorf2geneoftheneuropathogenicequineherpesvirustype1strainab4reducesvirulencewhilemaintainingstrongimmunogenicity
AT perkinsgillian deletionoftheorf2geneoftheneuropathogenicequineherpesvirustype1strainab4reducesvirulencewhilemaintainingstrongimmunogenicity
AT babasyansusanna deletionoftheorf2geneoftheneuropathogenicequineherpesvirustype1strainab4reducesvirulencewhilemaintainingstrongimmunogenicity
AT freerheather deletionoftheorf2geneoftheneuropathogenicequineherpesvirustype1strainab4reducesvirulencewhilemaintainingstrongimmunogenicity
AT wattschristina deletionoftheorf2geneoftheneuropathogenicequineherpesvirustype1strainab4reducesvirulencewhilemaintainingstrongimmunogenicity
AT rollinsalicia deletionoftheorf2geneoftheneuropathogenicequineherpesvirustype1strainab4reducesvirulencewhilemaintainingstrongimmunogenicity
AT osterriedernikolaus deletionoftheorf2geneoftheneuropathogenicequineherpesvirustype1strainab4reducesvirulencewhilemaintainingstrongimmunogenicity
AT wagnerbettina deletionoftheorf2geneoftheneuropathogenicequineherpesvirustype1strainab4reducesvirulencewhilemaintainingstrongimmunogenicity